31 results
IBD Therapeutic Drug Monitoring Thresholds
 - Infliximab > 7 mcg/ml
 - Adalimumab > 8 mcg/ml
 -
> 15 mcg/ml - ... > 14 mcg/ml - ... Monitoring #Thresholds #management ... #gastroenterology ... #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Internet Book of Critical ... Properties #Table #Pharmacology ... #Effect #Management
Pancreatic cystic lesions (PCLs)
 - classified into simple retention cysts, pseudocysts and cystic neoplasms 
 -
histological and clinical ... modalities for PCL ... lesions #PCLs #gastroenterology ... #diagnosis #management
Recurrent Polymorphic VT/Torsades de Pointes - Management Algorithm
Drugs that prolong QT interval:
 • Class 1a (quinidine,
Torsades de Pointes - Management ... Congenital long QT Syndrome ... 1 gm/hour • Pediatric ... /min • Pediatric ... TorsadesdePointes #TDP #Management
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... respiratory distress syndrome ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
association • M > F Clinical ... aseptic meningitis), MCC ... Disease: Arterial (MCC-small ... (Clinical Dx). ... #diagnosis #management
Single Syringe Adenosine - Instructions
1) Dilute 6-12 mg of adenosine in a syringe for a total
total volume: 20 mL ... patient's arm Clinical ... #Instructions #pharmacology ... SVT #cardiology #management
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Antiphospholipid Syndrome ... Anticardiolipin antibodies (aCL ... at least: • 1 clinical ... presence of 1 clinical ... APS #diagnosis #management
Naloxone - Toxicology

Adult starting dose:
 - 0.4 mg IV/IM/IO/SQ for non-opioid dependent patients
 - 0.04 mg
opioid-dependent patients Pediatric ... quantity to 1000 ml ... infusion at 100 ml ... Narcan #Toxicology #Management ... #Pharmacology #
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Stiff Person Syndrome ... Diagnosis and Management ... Clinical Manifestations ... Anti-GAD Ab (>1000u/ml ... SPS #Diagnosis #Management